Article info
PDFClinical ethics
A discussion on controversies and ethical dilemmas in prostate cancer screening
- Correspondence to Dr Satish Chandra Mishra, Department of Surgery, WHO Collaboration Centre for Research in Surgical Care Delivery in LMIC, Bhabha Atomic Research Centre Hospital, Mumbai, MH 400094, India; mishrasatishdr{at}gmail.com
Citation
A discussion on controversies and ethical dilemmas in prostate cancer screening
Publication history
- Received November 21, 2019
- Revised May 17, 2020
- Accepted May 22, 2020
- First published July 6, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (22 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
- Prostate cancer screening and the management of clinically localized disease
- Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
- The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study
- Clinically localised prostate cancer
- Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps
- Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
- Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
- Screening for prostate cancer remains controversial
- Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?